Clinical Trials Directory

Trials / Completed

CompletedNCT00604071

Sensitivity of the Home Macular Perimeter (HMP)

Sensitivity of the Home Macular Perimeter (HMP) in the Detection of Visual Field Abnormalities in Patients With Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD)- PILOT Study

Status
Completed
Phase
Study type
Observational
Enrollment
99 (actual)
Sponsor
Notal Vision Ltd. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

estimate the sensitivity of the HMP test in identifying visual field functional defects in subjects with CNV secondary to AMD

Detailed description

The HMP device is intended to aid patients in identifying their visual abnormalities and in addition to their own symptoms or Amsler grid use and aid in their prompt referral to eye care professional examination so clinical diagnosis can be made. As such the goal of the clinical plan is to demonstrate that patients who have CNV do demonstrate visual field abnormalities when tested with the HMP

Conditions

Timeline

Start date
2007-11-01
Primary completion
2008-09-01
Completion
2008-11-01
First posted
2008-01-29
Last updated
2015-04-14

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00604071. Inclusion in this directory is not an endorsement.

Sensitivity of the Home Macular Perimeter (HMP) (NCT00604071) · Clinical Trials Directory